Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Influenza, Human 2Central Nervous System Neoplasms 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × FluMist × Clear all
NCT00112112 2017-08-14

Safety Study to Evaluate FluMist in Immunocompromised Children

MedImmune LLC

Phase 1 Completed
20 enrolled 70 charts

Influenza, Human, Neoplasms

NCT00906750 2011-10-13

FMRESP

St. Jude Children's Research Hospital

Phase 1 Completed
56 enrolled

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡